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Abstract
FIC domain proteins mediate post-translational modifications of target proteins, which
typically results in their inactivation. Depending on the conservation of crucial active site
residues, the FIC fold serves as structural scaffold for various enzymatic activities, mostly
target adenylylation. The founding member of the vast Fic protein family, EcFicT, was
identified in Escherichia coli some time ago. The G55R point mutant of EcFicT displays
the “filamentation induced by cAMP” (Fic) phenotype at high 3’,5’-cyclic adenosine mono-
phosphate (cAMP) concentrations and elevated temperature, but the underlying molecu-
lar mechanism and any putative biochemical activity of EcFicT have remained unknown.
EcFicT belongs to class I Fic toxin proteins that are encoded together with a small inhibi-
tory protein (antitoxin), named EcFicA in E. coli. Here, we report the crystal structures of
two mutant EcFicT/EcFicA complexes (EcFicTG55RA and EcFicTAE28G) both showing
close resemblance with the structure of the AMP-transferase VbhT from Bartonella
schoenbuchensis in complex with its cognate antitoxin VbhA. However, crucial differ-
ences in the active site of EcFicT compared to VbhT and other AMP-transferases ratio-
nalize the lack of evidence for adenylylation activity. Comprehensive bioinformatic
analysis suggests that EcFicT has evolved from canonical AMP-transferases and has
acquired a conserved binding site for a yet to be discovered novel substrate. The G55R
mutation has no effect on structure or thermal stability of EcFicT, such that the molecular
basis for its associated Fic phenotype remains elusive. We anticipate that this structure
will inspire further bioinformatic and experimental analyses in order to characterize the
enzymatic activity of EcFicT and help revealing its physiological role.
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Introduction
Filamentation induced by cAMP (Fic) was discovered in the early 1980s by Utsumi et al. [1] as
a phenotype caused by the temperature sensitive allele fic-1 of the fic gene of Escherichia coli.
The G55R mutation encoded by the fic-1 allele caused cell filamentation at non-permissive
temperature (43°C) in the presence of high concentration of cAMP (1.5 mM) in the culture
medium [2–5]. In their reports, they showed that knock-out strains of the fic gene were viable
as wild-type. In contrast, bacteria expressing the fic-1 allele (G55R) displayed a filamentation
phenotype, suggesting a gain of functionmutation [3,4]. A complementation of the Δfic knock-
out mutant with the fic-1 allele also resulted in bacterial filamentation. Yet, the biochemical
function of the E. coli Fic protein remained unclear.
A few years ago, a biochemical activity likely shared by the majority of Fic proteins has been
identified by in vitro and in vivo analyses combined with mass spectrometry [6–9]. Representa-
tive members of FIC domain proteins containing the canonical HxFx[D/E]GNGR1xxR2 motif
were found to catalyze adenylylation (also known as AMPylation), the transfer of an AMPmoi-
ety from the ATP substrate onto a hydroxyl side-chain of a target protein. Crystal structures
showed that the ATP substrate interacts directly with arginines R1 and R2 and with the central
asparagine [9]. In addition, the substrate is indirectly bound to the aspartate or glutamate resi-
due of the Fic active site motif via a magnesium ion. The histidine is thought to constitute the
general base for deprotonation of the target hydroxyl side chain to allow in-line nucleophilic
attack onto the α-phosphorous of ATP. However, Fic proteins are versatile enzymes in that
they can also catalyze other post-translational modifications depending on their active site sig-
nature motif and the nature of the substrate binding pocket. Recent studies reported phospho-
cholination and phosphorylation (kinase) activity for AnkX [10] and Doc [11, 12],
respectively.
Catalytic activity is usually inhibited by a conserved inhibitory α-helix (αinh) that partly
obstructs the ATP binding site. The αinh can either be part of the same polypeptide chain
(located relative to the Fic domain N-terminal in class II Fic proteins and C-terminal in class
III Fic proteins, respectively) or provided by a separate small protein known as the antitoxin
(class I Fic proteins) [9]. The αinh helix contains a [S/T]xxxE[G/N] sequencemotif with the
invariant glutamate forming a salt-bridge with R2 of the FIC motif [9].
Structure/function studies on class I Fic proteins (designated as FicT toxins) and their cog-
nate antitoxins (designated as FicA) have focused so far on the toxin-antitoxin (TA) module
VbhTA of Bartonella schoenbuchensis [9,13–15]. VbhT was shown to interfere with bacterial
growth by adenylylation and concomitant inactivation of DNA gyrase and topoisomerase IV
[15]. The VbhA antitoxin inhibits the catalytic activity of VbhT by direct interaction, and
vhbA-vbhT is encoded in an operon like other ficA-ficT gene pairs. VbhTA and other FicTA
systems thus satisfy the key definition of a type II TA [15].
The fic gene of E. coli (renamed as ecficT) is preceded by the small upstream gene yhfG
(renamed as ecficA) that encodes a FicA antitoxin homolog and thus shares typical characteris-
tics of FicTA modules. The bona fide antitoxin EcFicA contains a canonical [S/T]xxxE[G/N]
inhibitionmotif and has been shown to interact with EcFicT [15,16]. Even upon mutation of
the inhibition motif, we were unable to demonstrate any auto- or target-adenylylation activity
catalyzed by EcFicT [15]. Similarly, any cellular target(s) and the mechanisms underlying “fila-
mentation induced by cAMP” have remained unknown.
Here, we describe the crystal structure of EcFicT in complex with its cognate antitoxin
EcFicA. Phylogenetic analysis reveals that enterobacterial FicT toxins constitute a distinct sub-
group that originated by vertical transmission and may have evolved a newmolecular and bio-
logical function. The crystal structure of the EcFicT/EcFicA complex reveals an extended
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ligand-binding pocket that is strictly conservedwithin this EcFicT-like subfamily. The precise
definition of this newly observed substrate-binding pocket will serve as a basis for in silico
docking experiments that will guide potential ligand identification and further bioinformatical
and evolutionary analyses of the Fic toxin-antitoxin family.
Materials and Methods
Phylogenetic analysis
The E. coli K12 MG1655 FicT protein (EcFicT; Uniprot: P20605) was used as reference
sequence for comparison with similar protein sequences (>50% identity) from the UniProt
Reference Clusters (UniRef) (702 sequences). For the phylogenies shown in the Supporting
Information, the protein list was shortened to 107 sequences by removing redundant entries.
For the phylogenies shown in the main figures, the protein list was further reduced to 47
sequences by applying a cut-off of 90% identity. Sequence alignments were created using Clus-
talW (implemented in Geneious v7.1.7; Biomatters) and manually curated. Subsequently,
gapped positions were removed and a maximum likelihoodphylogeny was constructed using
PhyML implemented in Geneious (LG substitution model as suggested by ProtTest3 [17], 100
bootstraps), including two distant class I Fic proteins, YeFicT of Yersinia enterocolitica str.
8081 and VbhT of B. schoenbuchensis. The phylogeny was rooted using VbhT as outgroup.
Phylogeny illustrations were processed using FigTree v1.4.2 (http://tree.bio.ed.ac.uk/software/
figtree). The sequence dataset described above was submitted to the SPEER server using the
SCI-PHY algorithm for automated subgrouping and a relative entropy value of 1.0 [18].
WebLogos for subgroups 1 and 3 were generated using theWEBLOGO server [19]. Addi-
tionally, the overall conservationwas monitored.
Analysis of the genetic loci of EcFicT homologs was performed using the www.
MicrobesOnline.orgweb tool [20] with a limit at 50 homologs and a clustering at 95% identity.
Only one representative locus is shown per species.
Cloning, expression and purification
Plasmids pPE0038 and pFVS0130 containing the E. coli ecficT/ecficA and ecficT/ecficAE28G
genes, respectively, were cloned in the pRSFDuet-1 vector (Novagen) as describedpreviously
[15]. Additionally, a single base-pairmutation was introduced in plasmids pPE0038 and
pFVS0130, resulting in plasmids pFVS0129 and pFVS0315 containing the ecficTG55R/ecficA
genes and ecficTG55R/ecficAE28G, respectively. EcFicT is fused to an N-terminal His6-tag and
EcFicA to an N-terminal HA-tag. Plasmids pPE0038, pFVS0129, pFVS0130 and pFVS0315
were transformed into E. coli BL21 (DE3). EcFicT/EcFicA (Uniprot: P20605/P0ADX5) protein
complexes were expressed and purified as describedpreviously for VbhTA proteins [9] using
the same buffer systems. EcFicTG55RA and EcFicTAE28G were concentrated to 25 and 28 mg/
mL, respectively.
Differential scanning fluorimetry analysis
Temperature-induced unfolding was monitored by differential scanning fluorimetry experi-
ments [21] performed on a Qiagen Rotor-gene Q real-time thermocycler as describedprevi-
ously [22].
Crystallization
Crystals were obtained at 20°C using the sitting-drop vapour diffusionmethod after mixing
0.2 μL protein solution with 0.2 μL reservoir solution equilibrating against a reservoir of 80 μL.
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EcFicTG55RA crystallizedafter 5 days in 0.2 MMgCl2, 0.1 M Tris pH 8.0 and 20% (w/v) PEG
6000 and EcFicTAE28G crystallizedafter 8 days in 19% PEG 1500, 0.1 MMMT (malic acid,
MES, Tris) buffer pH 6.0.
Data collection and processing
For data collection, crystals were cryo-protected by transfer into a reservoir solution supple-
mented with 20% glycerol and subsequently vitrified in liquid nitrogen. X-ray data were col-
lected at the Swiss Light Source (Villigen, Switzerland) on beamline X06SA (PXI) and X06DA
(PXIII) at 100 K and a wavelength of 1.000 Å. Diffractiondata were indexed and integrated
using XDS [23] and subsequently merged and scaled using XSCALE [23] or AIMLESS [24].
EcFicTG55RA and EcFicTAE28G diffracted to 2.0 Å and 2.4 Å, respectively. Data collection sta-
tistics are summarized in Table 1.
Structure determination
The structureswere solved by molecular replacement using PHASER [25]. The initial model of
the antitoxin was built using AUTOBUILD of the PHENIX package [26]. The complex models
were improved by iterative rounds of interactivemodel building using COOT [27] and refinement
using REFMAC5 [28] or PHENIX.REFINE [29]. Final refinement statistics are given in Table 2.
Table 1. Data collection statistics.
EcFicTG55RA EcFicTAE28G
PDB code 5JFF 5JFZ
X-ray source SLS X06DA (PXIII) SLS X06SA (PXI)
X-ray detector Pilatus 2M Pilatus 6M
Wavelength (Å) 0.9999 1.0000
Space group P 65 C 2
Cell dimensions
a, b, c (Å) 104.7, 104.7, 110.5 154.78, 64.40, 87.88
β (˚) 113.8
Matthews coefficient (Å3/Da) 3.1 2.51
Solvent content (%) 60.5 50.6
EcFicTA complexes per a.u. 2 3
Resolution limits (Å) 91–2.00 (2.07–2.00) 80–2.40 (2.49–2.40)
Rmerge † (%) 9.7 (86.5) 16.2 (66.5)
Rmeas ‡ (%) 10.3 (97.3) 17.7 (73.8)
CC 1/2 99.9 (83.2) 99.4 (75.7)
hI / σ(I)i 22.7 (2.9) 8.7 (2.0)
Total reflections 472’112 (43’939) 192’193 (16’376)
Unique reflections 46’196 (4’553) 30’850 (2’657)
Multiplicity 10.2 (9.7) 6.2 (6.2)
Completeness (%) 99.7 (98.7) 98.6 (85.8)
Mosaicity 0.14 0.25
Numbers in parentheses belong to the outer shell.
† Rmerge = ∑hkl∑i |Ii(hkl)—hI(hkl)i| / ∑hkl∑i Ii(hkl), where Ii(hkl) is the observed intensity for a reflection and hI(hkl)i is the average intensity obtained from
multiple observations of symmetry-related reflections.
‡ Rmeas = ∑hkl [N/(N-1)]1/2 ∑i |Ii(hkl)—hI(hkl)i| / ∑hkl∑i Ii(hkl), where Ii(hkl) is the observed intensity for a reflection, hI(hkl)i is the average intensity obtained
from multiple observations of symmetry-related reflections and N is the number of observations of intensity I(hkl).
doi:10.1371/journal.pone.0163654.t001
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Accession numbers
Coordinates and structure factors have been deposited in the Protein Data Bank with accession
numbers 5JFF and 5JFZ for EcFicTG55RA and EcFicTAE28G, respectively.
Results
EcFicT and EcFicA form a stable complex
Co-expression of ecficT and ecficA in E. coli BL21 (DE3) yielded over 15 mg of soluble complex
per liter of culture. Size exclusion chromatography coupled to multi-angle laser light scattering
(SEC-MALLS) analyses revealed that all investigated constructs—wild-typeEcFicTwt/EcFicAwt
complex (EcFicTA), single mutants EcFicTG55R/EcFicAwt (EcFicTG55RA) and EcFicT/EcFi-
cAE28G (EcFicTAE28G), and double mutant EcFicTG55R/EcFicAE28G (EcFicTG55RAE28G)—form
a stable 1:1 complex, with a molecularmass between 32.1 kDa to 32.9 kDa, which closely corre-
sponds to the theoretical mass of 33.4 kDa (Fig 1A).
Purified EcFicTA complexes were subjected to differential scanning fluorimetry (DSF) to
determine their melting temperature (Tm). Wild-type EcFicTA appears rather stable with a Tm
of 63°C (green curve, Fig 1B). The G55R mutation that has been shown originally to cause in
vivo the Fic phenotype [1] does not affect the melting temperature of the complex (EcFicT-
G55RA variant, blue curve, Fig 1B) despite additional intra-molecular interactions (see below).
The melting curve appears monophasic. Thus, it is likely that the two proteins melt coopera-
tively, but we cannot exclude that both proteins have similar individual melting temperature.
Strikingly, mutation of the putative inhibitory glutamate residue E28 (EcFicAE28G) decreases
the melting temperature of the complex by 10°C compared to the wild-type complex (Fig 1B).
The peaks of the first derivative of the melting curve of EcFicTAE28G and EcFicTG55RAE28G
appear to broaden towards lower temperature, indicating that the E28Gmutation may weaken
the complex stability, resulting in a partial dissociation of EcFicAE28G from EcFicT.
Structure determination of EcFicT/EcFicA complexes
Crystallization trials of the wild-type EcFicTA complex did not yield any detectable crystal.
However, the EcFicTG55R mutant in complex with EcFicA (EcFicTG55RA) yielded crystals that
diffracted to 2.0 Å. Crystals belonged to the Laue group 6/m with unit cell parameters
a = 104.69 Å, b = 104.69 Å and c = 110.52 Å. Systematic absences along the c-axis (0,0,l) indi-
cated space groups P61 or its enantiomorph P65. Unit cell parameters and space group sug-
gested two 1:1 complexes per asymmetric unit (2.60 Å3/Da). The structure of EcFicTG55RA was
determined at 2.0 Å resolution (Table 1) by molecular replacement using the structure of
VbhT (33% sequence identity to EcFicT) from the VbhTA complex (PDB: 3ZC7) as search
model (Fig 2A). All possible space groups were tested for molecular replacement using PHA-
SER [25]. The best solution (TFZ = 11.6 and LLG = 206) was obtained in space group P65 yield-
ing two EcFicT molecules in the asymmetric unit. Initial refinement (Rwork = 43.6%, Rfree =
47.0%) showed additional α-helical structure (positive Fo-Fc map) in the groove of the Fic pro-
tein next to the active site, where usually the αinh helix is found [9,13]. After automatic model
building of this part followed by several cycles of iterative model building and refinement, an
almost complete full model of the EcFicTG55RA complex was obtained with Rwork and Rfree val-
ues of 17.7% and 20.4%, respectively. Final refinement statistics and completeness of the model
are given in Table 2.
For EcFicT in complex with the antitoxin mutant EcFicAE28G, crystals of the monoclinic
space group C2 were obtained that diffracted to 2.4 Å, containing three toxin-antitoxin com-
plexes per asymmetric unit. The structure of EcFicTAE28G was solved by molecular
E. coli Fic Toxin-Like Protein in Complex with Its Cognate Antitoxin
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Table 2. Refinement statistics.
EcFicTG55RA EcFicTAE28G
PDB code 5JFF 5JFZ
Resolution limits (Å) 90.66–2.00 (2.07–2.00) 80.41–2.40 (2.49–2.40)
Rwork * (%) 17.7 (23.4) 21.7 (27.7)
Rfree ** (%) 20.4 (28.7) 26.8 (35.1)
Number of non-hydrogen atoms 4’294 5’560
proteins 3’887 5’413
ligands 6 0
solvent 401 147
Completeness of model
EcFicT (residues) 10–15, 17–198 10–81, 88–195
EcFicA (residues) 3–53 5–53
Protein residues 478 686
R.m.s.d from ideal
Bond lengths (Å) 0.019 0.013
Bond angles (˚) 1.73 1.53
Ramachandran favored *** (%) 99 99
Ramachandran outliers *** (%) 0 0
Clashscore *** 3.12 2.92
Average B values (Å2) 30.20 33.70
macromolecules 29.60 33.80
ligands 40.50 n.a.
solvent 35.70 29.90
Numbers in parentheses refer to the outer shell.
* Rwork = ∑hkl|| Fobs|—|Fcalc|| / ∑hkl|Fobs|
** Rfree is the R value calculated for 5% of the data set that was not included in the refinement.
*** Molprobity
doi:10.1371/journal.pone.0163654.t002
Fig 1. Analysis of the various EcFicTA complexes in solution. (a) SEC-MALLS analysis of EcFicTA (green), EcFicTAE28G (pink), EcFicTG55RA (cyan)
and EcFicTG55RAE28G (purple) reveals in each case a 1:1 complex in solution at an eluting concentration of 15 μM. (b) Differential scanning fluorimetry
(DSF) analysis of EcFicTA variants. Melting curves (continuous lines) and their first derivatives (broken lines) are shown. Complexes with the E28G
mutation in the antitoxin show decreased stability compared to the wild-type complex, whereas the G55R mutation does not affect the thermal stability of
the complex.
doi:10.1371/journal.pone.0163654.g001
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replacement using the previously determined structure of EcFicTG55RA (PDB code: 5JFF) as
search model. Data collection statistics, refinement statistics and completeness of the model
are given in Tables 1 and 2, respectively. For both structures determined in this study, the
geometry of the final model was assessed using MolProbity [30] showing>99% of the residues
in the core and allowed regions of the Ramachandran plot.
Structure analysis of the EcFicT/EcFicA complexes
Despite distinct crystal packings, the structures of EcFicTG55RA and EcFicTAE28G are virtually
identical (root mean square deviation (rmsd) of 0.59 Å for 232 Cα-atoms). In particular, the
interactions formed between the Fic protein and the antitoxin are the same, giving confidence
that they are physiological and also occur in solution. Biological relevance of this interface was
also corroborated by EPPIC (Evolutionary Protein-Protein Interface Classifier [31]) analysis.
No other interfaces of potential biological significancewere identified
Fig 2. Structure comparison of EcFicTG55R/EcFicA with VbhT/VbhA. (a) Overall structure of the
EcFicTG55R/EcFicA complex. (b) Close-up view of the EcFicT active site with the active-site loop highlighted in
yellow. Residues S24, R25 and E28 of EcFicA form a lock via three H-bonds with residues R146 and T40 of
EcFicT. (c) Overall structure of the VbhT/VbhA complex (PDB: 3ZC7 [13]). The ATP substrate is shown in full.
(d) Close-up view of the active site of VbhTA. In (a) and (c), the Fic proteins are shown as solvent accessible
surface representation and the antitoxins in cartoon representation with the αinh highlighted by a stronger hue.
In (b) and (d), the active sites are shown in detail with the signature motif in yellow. H-bonds are shown as
dashed lines.
doi:10.1371/journal.pone.0163654.g002
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EcFicT is highly similar to other Fic domain structures. In particular, EcFicTG55R superim-
poses very well with the structure of VbhT from B. schoenbuchensis and BepA from Bartonella
henselae, with an rmsd of 1.36 Å and 1.65 Å for 187 and 189 Cα-atoms, respectively. Notewor-
thy, the pairwise sequence identity of EcFicT with both VbhT and BepA is rather low (33% and
32%, respectively). EcFicT forms a seven α-helices bundle with the Fic signature motif located
betweenα4 and α5. The flap is located between helices α2 and α3 and forms a beta-hairpin
(S1A Fig) that has been previously shown [32] or predicted to be involved in target docking
[13,33,34]. The Fic core, as defined by pfam (pfam 02661 [35]), includes residues 54–157 and
comprises helices α2 to α5 (S1A Fig).
The EcFicA antitoxin tightly embraces EcFicT forming mainly hydrophobic interactions, as
observed also in the VbhA/VbhT complex (Fig 2). Yet, EcFicA adopts a unique conformation,
forming two parallel α-helices linked by a 10-residues loop (Fig 2A) compared to VbhA that
forms three anti-parallel α-helices (Fig 2C). The second helix of VbhA is degenerated to a loop
in EcFicA. Sequence alignment reveals an eight amino acids deletion in EcFicA compared to
VbhA (S2 Fig). Furthermore, the first helix of EcFicA (α1) that is homologous to the αinh helix
is kinked and two amino acids longer than the corresponding helix of VbhA. The kink occurs
at the same position as in PhD, the antitoxin of the Doc toxin from Bacteriophage P1, although
the angle and direction are different (S1B Fig).
The SRRLEG segment at the C-terminal end of the first helix of EcFicA (Fig 2B) conforms
to the canonical [S/T]xxxE[G/N] inhibition motif and protrudes into the EcFicT active site as
in the VbhTA complex. S24 and E28 of EcFicA form, respectively, H-bond and salt-bridge
interactions with R146 (R2) of the canonical Fic signature motif (compare Fig 2B with Fig 2D).
Additionally, R25 of EcFicA interacts with T40 of EcFicT (Fig 2B). An interface of 1641 Å2 is
formed between EcFicT and EcFicA, corresponding to a gain in free energy (ΔiG) of -19.6 kcal/
mol upon formation of the interface as calculated by the PISA web server [36]. This interface is
mainly hydrophobic: 13 residues of EcFicA (out of 33) are hydrophobic and contribute to a
buried surface area of 727 Å2 and 17 residues of EcFicT (and out 44) are hydrophobic and con-
tribute to a buried surface area of 710 A2. This large and hydrophobic interface is consistent
with the stable complex that has been observed in solution (Fig 1).
Phylogenetic analysis of EcFicT homologs
In order to obtain insight into the functional evolution of EcFicT, we generated a multiple
sequence alignment comprising 702 sequences of EcFicT homologs down to 50% sequence
identity, which was reduced to 102 sequences by manually removing redundant sequences (S3
Fig). Interestingly, these close EcFicT homologs all belong to Enterobacteriaceae, indicating
that vertical transmission and not horizontal gene transfer played a major role in their evolu-
tionary history. This hypothesis is strongly supported by the finding of largely syntenic loci for
all close enterobacterial homologs of EcFicT, but no conserved genetic associations for other,
distantly related, FicTA modules (S4 Fig). The inferred vertical transmission of the genes cod-
ing for EcFicT-like proteins contrasts with the situation found for type II toxin-antitoxin mod-
ules that, during evolution, are typically transmitted via horizontal gene transfer [37]. The
same has been recently suggested for FIC domain proteins in general [38].
The phylogenetic relation between the sequences of the multiple sequence alignment as
derived from a maximum-likelihoodanalysis is shown in S3 Fig, and a reduced version of the
tree (after filtering out redundant sequences with> 90% identity) is given in Fig 3A. The phy-
logeny was rooted using VbhT, a very distantly related FicT toxin of B. schoenbuchensis, and
additionally contains the distinct, yet enterobacterial YeFicT toxin for comparison [15]. These
two proteins and ancestral branches of the tree (subgroup 1, yellow background in Fig 3A and
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S3 Fig) form a group of rather distant EcFicT homologs (sequence identity between 50% and
60%). Most group members harbor the asparagine and both arginines of the canonical HxFx
[D/E]GNGR1xxR2 adenylylation-competent motif, and the AMPylation activity of VbhT has
been demonstrated [15]. Subgroup 2 (shown in the middle of the tree) is characterized by a
specific pattern at the N-terminus.While all the analyzed sequences are of very similar length,
a five amino-acids deletion appears at the N-terminus of subgroup 2 sequences. Conspicuously,
this group and the EcFicT-like homologs (subgroup 3; displayed at the bottom of the tree with
purple background in Fig 3A and S3 Fig) have signature motifs that differ from the ancestral
state in subgroup 1. Compared to the canonical sequence, a small to medium-sized hydropho-
bic residue invariably substitutes arginine R1 that in AMP transferases is heavily involved in
ATP binding [9,13] suggesting that these proteins are not adenylylation-competent and may
have evolved a new biochemical function.
Specificity determining positions that distinguish EcFicT from canonical
FIC AMP transferases
To validate the subgrouping derived from the phylogenetic analysis and to systematically iden-
tify subgroup defining positions (SDPs), we submitted the multiple sequence alignment to the
SPEER server (specificity prediction using amino acid’s properties, entropies and evolution
rate [18]). Four subgroups (I–IV) were identified by SPEER as indicated in S3 Fig that matched
almost perfectly the grouping derived from the phylogenetic analysis, though with subgroup 1
being divided in two parts (SPEER groups II and IV).
To reveal the SDPs, we computed the sequence logos for the subgroups of canonical AMP
transferases (subgroup 1) and of EcFicT-like proteins (subgroup 3), which are displayed in Fig
3B in the top and bottom row, respectively. While about 40% of the residues are almost strictly
conserved amongst the two subgroups (marked in grey on Fig 3B), there are several residues
that are conserved only in one or the other subgroup (marked with magenta or red back-
ground, respectively). These SDPs are found throughout the entire sequence and their number
is considerably larger in the EcFicT-like than in the canonical subgroup (12 magenta vs. 43 red
positions). Possibly, this reflects additional evolutionary constraints on the structure and func-
tion of the EcFicT-like proteins. While many of the SDPs correspond to buried residues (see
also Fig 3C) that, thus, would have maintained their specificity for structural reasons, there are
also several positions that are exposed and probably related to function. Latter positions map
to (i) the canonical ligand-binding pocket, (ii) the flap that is expected to interact with a puta-
tive target, and (iii) the N-terminus (Fig 3C). Some additional positions were manually
Fig 3. Phylogenetic and SDP analysis of EcFicT-like sequences. (a) Comprehensive phylogeny of representative sequences of the EcFicT-like
subfamily of class I Fic proteins. The maximum likelihood phylogeny was rooted using the FIC domain of VbhT, a distantly related FicT protein of B.
schoenbuchensis, as an outgroup and included the FIC domain of YeFicT of Yersinia enterocolitica str. 8081 FicT (YeFicT) for comparison [15].
Bootstrap support for individual branches is indicated by color code on the nodes. Yellow background coloring indicates the presence of a canonical
FIC domain active site motif (subgroup 1), and the tree topology reveals that this is the ancestral state among the enterobacterial FicT homologs. The
other sequences display different degrees of degeneration of the active site sequence (subgroups 2 and 3; see also S3 Fig). Among these, a group of
FicT proteins of Enterobacter are hallmarked by a distinctive sequence variant at their N-terminus (in subgroup 2; no background coloring, see also S3
Fig). Purple background coloring refers to close homologs of EcFicT (subgroup 3) (b) Aligned weblogos of distant (subgroup 1, yellow) and close
(subgroup 3, purple) EcFicT homologs, shown in the top and bottow row, respectively. Residues with a larger than 75% overall conservation are
shown in grey and represents residues that do not confer subgroup specificity. Residues conserved by more than 75% but only within one of the
subgroups are colored in magenta (top row) or red (bottom row) and indicate SDPs. Additionally, variable subgroup 3 residues homologous to
positions important for the AMP-transferase activity of subgroup 1 members are highlighted in green. Residues discussed in the manuscript are
indicated by stars. The flap and active site are indicated. (c) Specificity determining positions (SDPs) are shown in stick representation on the crystal
structure of VbhTA (left, PDB: 3ZC7) and EcFicTG55RA (right). Note that ATP in competent conformation has been obtained by superimposition with
the structure of VbhTAE24G (PDB: 3CZB).
doi:10.1371/journal.pone.0163654.g003
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identified (shown in green). These positions are slightly variable in each subgroup and, there-
fore, not picked up automatically using a sequence identity threshold.
Consistent with our preliminary assignment as canonical AMP transferases, subgroup 1
exhibits an almost canonical HPFR0(D/E)GNGR1xxR2 signature motif. The R1 position is
clearly a SDP for that group and contrasts strongly with the small to medium-sized hydropho-
bic residue in EcFicT-like proteins (subgroup 3). The conserved central asparagine residue is
foundmutated to a serine in about half of the EcFicT-like sequences. The full phylogeny of sub-
group 1 (S3 Fig) reveals that this asparagine to serinemutation has occurred several times inde-
pendently. An asparagine or a serine can most likely adopt this position without altering the
H-bond interaction with the main-chain amide of the strictly conserved structural phenylala-
nine of the signature motif (F137 of EcFicT). Unexpectedly, the D/E residue of the canonical
motif (E140 in VbhT) that is involved in Mg2+ coordination in known structures (Fig 3C, left)
is not well conserved in subgroup 1. It would be interesting to further functionally characterize
this group with respect to magnesium requirement. In subgroup 3, the equivalent position is
almost invariably a leucine or isoleucine.
There are several additional SDPs close to the site that binds ATP in VbhT (subgroup 1, Fig
3C). In VbhT, the aforementioned R1 (R144) is close to F68; in EcFicT, the corresponding resi-
dues are L143 and Y67 (Fig 3C). In VbhT, a tyrosine at position 68 would clash with arginine
R1. It is noteworthy, that Y67 of EcFicT is interacting indirectly with R25 of the antitoxin via a
water molecule. Removal of the antitoxin may open up a binding site for a yet unidentified sub-
strate potentially involving this tyrosine.
Strikingly, a highly conserved glutamate of subgroup 1 (E35 of VbhT) is mutated to alanine
(A36 of EcFicT) in most subgroup 3 sequences. The glutamate interacts with R1 and thus, the
glutamate to alanine change may represent co-variation with the R1 to hydrophobic amino
acid mutation (Figs 3C and 4). Finally, a strict tyrosine to phenylalanine change is apparent in
position 72 of VbhT (71 in EcFicT), bordering the signature loop. In summary, next to the sig-
nature loop, EcFicT-like proteins exhibit an extended groove lined by hydrophobic residues
(A36, F71, V139) and bordered by the polar residues Y67 and T40 with exposed hydroxyl
groups (Fig 4). All 5 positions are SDPs, i.e. specifically conserved is subgroup 3. It is well con-
ceivable that EcFicT-like proteins have evolved this binding pocket to accommodate a substrate
distinct from ATP used by canonical AMP transferases (S5 Fig).
Fig 4. Putative hydrophobic substrate-binding pocket of EcFicT. (a) EcFicTA structure in a similar view and
representation as in Fig 2A, but with positively charged atoms colored in blue and negatively charged atoms
colored in red. Hydrophobic atoms are shown in white, except atoms of the active site loop that are highlighted in
yellow. (b) A rotation of 45˚C around a vertical axis reveals an additional hydrophobic pocket.
doi:10.1371/journal.pone.0163654.g004
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Also at the flap and close to it, several residues are well-conserved in the EcFicT-like sub-
group. In particular, E79 and Y83 are interesting, since they are exposed and may provide spec-
ificity for the interaction with a yet unidentified target protein. The strictly conserved alanine
and methionine at positions 178 and 179, respectively, are located just below the flap and may
thus be important for proper positioning of the flap for target recognition and registration of
the modifiable segment. The overall analysis of the conservation of amino acids at the surface
of EcFicT-like Fic proteins reveals two well-conservedpatches: the first one located below the
flap (residues 123, 126, 130, 133, 175 and 178–180) and a second one on the “back” of the Fic
protein (residues 92, 96, 100, 103, 107), seeWeblogo on Fig 3B and ConSurf representation on
Fig 5. These two patches may be involved in target recognition of a subgroup specific target
that remains to be discovered.
Putative regulation of FicT proteins by tyrosine auto-modification
The sequence logos of Fig 3B reveal a DPY motif that is strictly conserved in subgroups 1 and
3. In the crystal structure of EcFicTA, the first eight amino acids of EcFicT are unresolved,
but the structure of the DPY motif (residue numbers 10–12) is resolved. Fig 6A shows that
the aspartate (D10) and tyrosine (Y12) side-chains interact with the side-chain of arginine
R138 (4th residue of the Fic signature motif, referred to as R0) and the main-chain amide of
residue 79 (preceding the flap), respectively. The same organization can be seen in the apo
VbhTA crystal structure [9]. This interaction may be crucial for the observed fixation of the
VbhT N-terminus to the flap (Fig 6B), which is the docking site for the modifiable segment
of the target as e.g. observed in IbpAFIC2/Cdc42 (Fig 6C) [32] and inferred from other Fic
structures that show a chain-terminus from an adjacent Fic molecules in the crystal bound to
this site [13].
The interaction of the N-terminus with the target dock, which had been over-looked so far,
may constitute a physiological auto-inhibition mechanism (N-terminal lock), since, obviously,
it would impede productive target binding.
Fig 5. Sequence conservation of EcFicT. Surface representation of EcFicT colored by conservation with a
cyan-white-purple gradient for variable to conserved residues. EcFicA is shown in yellow with the αinh helix in gold.
The strictly conserved residue G55 is indicated.
doi:10.1371/journal.pone.0163654.g005
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In analogy to the relief of auto-inhibition exerted by the auto-modification of the αinh in
NmFic and probably most of class III Fic proteins [22], it is tempting to speculate, that also the
conserved tyrosine of the DPY motif can get auto-modified to relieve auto-inhibition. It is
striking that R0 of the Fic motif is highly variable in adenylylating Fic enzymes in general, but
strictly conserved in subgroups 1 and 3 of Enterobacterial class I Fic proteins (see [15] and also
S3 Fig). Noteworthy, the DPY motif is absent in subgroup 2 sequences (S3 Fig), which corre-
lates perfectly with the residue homologous to R0 being a non-arginine. Thus, the conservation
of R0 in subgroups 1 and 3 may indeed indicate its functional role in the N-terminal lock
stabilization.
Effect of the EcFicTG55R mutation
Our crystal structures show that the G55R mutation encoded by the fic-1 allele, which results
in the cell filamentation phenotype [3], does not affect the structure of EcFicT (see above and
Fig 7A). The Ramachandran angles of R55 (F, C = -120.7, -160.4) are virtually the same as
those of the G55 wild-type residue (F, C = -133.6, -155.8 as measured in the EcFicTAE28G
structure). The arginine 55 side-chain forms a salt-bridge with glutamate 107 of helix α3 (Fig
7B), which is conserved in EcFicT-like homologs (Fig 3B). One could speculate that the glycine
to arginine mutation may reduce the main-chain flexibility. However, despite the additional
salt-bridge, the G55R variant is not more stable than the wild-type protein, as has been shown
above by DSF (Fig 1B).
Fig 6. N-terminal lid-lock of class I Fic proteins. (a) EcFicTG55RA structure depicted as cartoon
representation with EcFicTG55RA colored in beige (active site loop in yellow, flap in light blue). The DPY motif
(residues 10–12) is colored in pink. EcFicA is colored in blue. (b) The apo structure of VbhTA (PDB: 3SHG
[9]) is depicted in a similar view and representation as EcFicTG55RA in panel (a). VbhA is colored in green.
The N-terminal VbhT segment is colored in pink. Note that a tartaric acid molecule is bound to the active site
of VbhT (not shown). In (a) and (b), H-bonds between the N-terminal segment and the flap or active site
residues are shown as dashed lines. (c) For comparison, interaction of the modifiable segment of Cdc42 to
the flap of IbpAFic2 in the IbpAFic2/Cdc42 complex structure (PDB: 4ITR [32]).
doi:10.1371/journal.pone.0163654.g006
Fig 7. Structural comparison of EcFicTAE28G and EcFicTG55RA. (a) Superimposition of the two structures
determined in this study reveals a well-conserved Cα-trace with an rmsd of 0.55 Å for 229 atom pairs of the
EcFicTA complexes. (b) Close-up view of the salt-bridge formed between R55 and E107 in the EcFicTG55RA
complex. Note that the two crystal structures were obtained from two different crystal forms (space groups P65 and
C2 for EcFicTG55RA and EcFicTAE28G, respectively; see Table 1 for details).
doi:10.1371/journal.pone.0163654.g007
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Effect of the EcFicAE28G mutation
EcFicTAE28G crystallized in the space group C2 with three complexes per asymmetric unit. The
structure of this mutant is virtually identical to that of EcFicTG55RA, except for disorder of resi-
dues 83–86 at the tip of the flap. In EcFicTG55RA, the flap is stabilized by crystal contacts and is
fully ordered. The lack of electron density of the flap of the E28Gmutant has already been
observed in several other FIC domain protein structures (e.g. Bep1 from Bartonella clarridgeiae,
PBD: 4NPS or NmFicE102R fromNeisseria meningitidis, PDB: 5CGL).We speculate that, in
solution, this region gets stabilized only upon substrate and/or target binding and that it is
likely to be disordered for EcFicTG55RA too.
In canonical AMP-transferases, the conserved glutamate of αinh is engaged in a salt-bridge
with arginine R2 of the Fic motif, thereby preventing competent ATP binding. Also in EcFicT-
G55RA, such an intermolecular salt-bridge is observed (E28–R146). Though the side-chain
truncation in EcFicAE28G increases the size of the putative substrate binding site, it may not be
sufficient to allow productive substrate binding and relieve the inhibition of EcFicT. Because of
the hydrophobic pocket on the left-hand side of the active site that may accommodate a differ-
ent substrate, de-binding of EcFicA or more drastic mutations may be required to allow ligand
binding.
Discussion
The Fic protein from E. coli (now named EcFicT) was identifiedmore than 30 years ago [1]
and was shown to be responsible for the filamentation induced by cAMP (fic) phenotype when
carrying a G55R amino acid exchange (encoded by the fic-1 allele), but its molecular and bio-
logical function remained elusive.
Since then, a number of Fic proteins from other organisms have been shown to catalyze ade-
nylylation of target proteins, resulting in modulation of their functions, e.g. by inhibiting Rho-
GTPase pathways or bacterial DNA topoisomerases [6,7,15,39]. The vast majority of adenylyla-
tion-competent Fic proteins are expressed in an inhibited form [9]. The location of the inhibi-
tion motif lead to the classification of Fic proteins in class I, II and III depending on this motif
being contributed by an antitoxin, or found at the N-terminal or C-terminal end of the Fic pro-
tein, respectively. According to this classification, EcFicT belongs to class I with the inhibitory
helix provided by EcFicA, a small protein coded immediately upstream of the ecficT gene. The
synteny of the corresponding genetic loci reveals that the genes were primarily transmitted ver-
tically within the Enterobacteriaceae , suggesting a specific physiological function. This is in
contrast to typical type II TA modules that show considerable mobility via horizontal gene
transfer, likely related to their biological functions in the context of mobile genetic elements
[40].
The crystal structure of the tight EcFicTA complex reported in this study shows that the
EcFicT protein adopts the canonical fold with a somewhat degenerated signature motif and
that it is embraced by the cognate EcFicA antitoxin very similarly as in the AMP-transferase
VbhTA complex [9]. The inhibitory glutamate of EcFicA forms a salt-bridge with the last argi-
nine (R2) of the Fic motif of EcFicT, as in VbhTA (Fig 2B and 2D). Despite the close similarity,
the structure suggests that EcFicT most likely does not bind ATP, consistent with the lack of
any evidence for auto-adenylylation [15]. In this respect, the presence of a leucine residue
instead of the canonical arginine R1 appears most relevant. R1 interacts with the β-phosphate
of the ATP substrate in the inhibition relieved form of VbhT [13] and with the α-phosphate of
CDP-choline in AnkX [41] (S5 and S6 Figs). Still, in EcFicT, binding of a diphosphate moiety
to the anion-binding nest at the N-terminus of the helix appears still sterically feasible due to
the conservation of the second glycine of the signature motif (Fig 3B). Another salient
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difference seen in EcFicT is the presence of a hydrophobic residue at the position following R0
(Fig 3B), which in canonical FIC AMP-transferases is taken by a charged residue to form a
direct (lysine, PDB: 4WGJ, SSGCID) or indirect (glutamate via a Mg2+ ion) interaction with
substrate phosphate(s). The adenine-binding pocket as observed in VbhT appears present in
EcFicT and the asparagine preceding the Fic signature motif is strictly conserved in EcFicT
homologs (subgroup 3, Fig 3B). In the EcFicTG55RA structure, the base-binding pocket is nev-
ertheless partly restricted by the conformation that adopts the glutamine 84 of EcFicT located
at the tip of the flap. The flap is a rather flexible part of the protein and likely only stabilizes
upon target binding or artificially by crystal contacts in x-ray structures. An alternative rotamer
and/or a slight different conformation of the flap would result in an unrestricted base-binding
pocket.
The comparative analysis of EcFicT-like and Fic AMP-transferase sequences not only
showed that the two aforementioned charged residues of AMP-transferases are replaced by
hydrophobic residues in EcFicT-like proteins, but that there are about a dozen subgroup defin-
ing positions (SDPs) (Fig 3). Since many SDPs of the EcFicT subgroup are localized close to
the signature motif, it appears likely that they are involved in binding of a yet unidentified sub-
strate. If in addition R2 were also involved in substrate binding, its interaction with the inhibi-
tory antitoxin glutamate may again, as in e.g. VbhTA toxin-antitoxin complex, compromise
substrate binding and, thus, inhibit the putative catalytic activity. Additional SDPs of EcFicT-
like proteins cluster at the exposed face of the flap and in the N-terminal segment (Fig 3C,
right). These positions may well be conserved for subgroup-specific recognition of a putative
target protein.
Phylogenetic analysis showed that EcFicT has evolved out of canonical AMP transferases in
the Fic protein family (Fig 3A and S3 Fig). Considering the well-defined and conserved struc-
tural features of EcFicT-like proteins, we suggest that during evolution the Fic structure has
been reshaped to accommodate a yet unidentified substrate, and to recognize a new range of
targets. Interestingly, the histidine, crucial for deprotonation of the incoming target side-chain
hydroxyl group, remains conserved in EcFicT-like proteins.
Class I Fic proteins in general show a conservedDPY segment that seems to tether the N-
terminal segment to the body of the FIC domain as observed in EcFicT, but also in the VbhT
structure (Fig 6A and 6B). Interestingly and underappreciated in our previous work [9], the
very N-terminus of VbhT (which is unresolved in the EcFicT structure) is laterally bound to
the flap, thereby augmenting the small β-sheet, in a similar manner as observed for target pep-
tide binding (Fig 6C) [32]. This finding suggests that class I Fic protein may have, apart from
the inhibitory glutamate preventing competent substrate binding, another auto-inhibitory ele-
ment competing with target binding. In the light of recent reports that auto-adenylylation can
relieve auto-inhibition in Fic proteins [22,42], we note that the conserved tyrosine of the N-ter-
minal DPY motif (Y12 of EcFicT) is buried (Fig 6A) and that, therefore, its modificationwith a
bulky group may interfere with binding of the N-terminal segment to the target dock and
therefore relieve inhibition.
The “filamentation induced by cAMP” phenotype is hallmarked by the inhibition of cell
division in an environment of elevated temperature and cAMP concentrations (43°C) and
caused by the fic-1 allele of ecficT [1]. The EcFicTG55RA crystal structure revealed that the site
of mutation is neither close to the presumed active site nor the presumed target recognition
site. The comparison of the thermal stability of EcFicTA and EcFicTG55RA revealed the same
melting temperature for both complexes (Fig 2B). But, once dissociated from its cognate part-
ner EcFicA, the melting temperature of EcFicTmay be more severely decreased than the one of
EcFicTG55R. Furthermore, it has been suggested in a recent review [43] that the G55R mutation
may result in "long-range conformational changes that facilitate the dissociation of the
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corresponding antitoxin". However, we did not observe such effects as the EcFicTAE28G and
EcFicTG55RA structures are very similar. Also, the oligomeric state of the EcFicTA protein
complex is not affected by the mutation (Fig 2A). Nonetheless, we cannot exclude that upon
unbinding of the antitoxin, long-range structural changes may occur. Noteworthy, the Doc
toxin (mutant H66Y) forms a sub-domain swapped dimer in absence of its cognate PhD anti-
toxin [44]. Our structural work does not provide an explanation or potential mechanism for
the results obtained for the originally describedFIC domain protein EcFicT [1]. Further experi-
ments, such as ligand docking combined with biochemical analyses, may help revealing the
role of enterobacterial FIC-domain proteins.
Conclusion
The E.coli Fic protein EcFicT forms a tight complex with its cognate antitoxin EcFicA. EcFicT
adopts the conservedFic fold, but with a distinct active site signature motif and an additional
hydrophobic binding pocket in the vicinity of the active site loop. EcFicA forms two parallel α-
helices that tightly embrace EcFicT. The structural information provided in this manuscript
may serve as a basis to identify new potential substrates of Fic proteins with EcFicT-like active
site motif, if combined with the appropriate bioinformatical ligand docking experiments. Still,
further in silico, in vitro and/or in vivo analyses are required to understand the activity of the
first describedFIC domain protein.
The combination of cognate FicA antitoxins and the N-terminal lock may form a double-
lock mechanism of regulation for class I Fic proteins. This may be analogous to the double-
lock mechanism of class III Fic proteins via oligomerization and auto-adenylylation that we
have recently described [22]. Given that all structural features required for the two mechanisms
of catalysis regulation are fully conserved in the EcFicT-like subfamily, we find it likely that
these proteins are indeed enzymes whose catalytic activity merely remains to be uncovered.
Taken together, we propose that the EcFicT-like subfamily of class I Fic proteins has
adapted the conservedFIC domain fold for a new (possibly catalytic) molecular activity in the
context of a biological function outside the framework of classical FicTA toxin-antitoxin mod-
ules that disrupt DNA topology [15].
Supporting Information
S1 Fig. Comparison of the antitoxin-binding mode in the EcFicTA and Doc/PhD com-
plexes. (a) Cartoon representation of the EcFicTG55RA complex. EcFicTG55R is colored in beige
with the active site loop highlighted in yellow and EcFicA is colored in light blue with the αinh
helix highlighted in dark blue as in Fig 2A. (b) Cartoon representation of the Doc/PhD complex
in the same orientation as the EcFicTG55RA complex shown in panel a. Doc is colored in light
brown with the active site loop highlighted in yellow and PhD is colored in sea green. Doc is a
homolog of EcFicT and both proteins belong to the Fido protein family [45]. Note that the
kink in the helix of the antitoxin occurs at the same position in both rather distant complexes.
(TIF)
S2 Fig. Protein sequence alignment of VbhA and EcFicA.The inhibition motif is depicted by
a yellow rectangle and the position of the α-helices as observed in the crystal structures are
depicted as blue cylinders. The residue numbers correspond to the amino acids numbers in
each protein sequence. Red lines indicate structurally equivalent residues.
(TIF)
S3 Fig. Full alignment of Enterobacterial EcFicT homologs.The phylogeny of Fig 3A is
shown in an extended view (left) for comparison with a full-length alignment of the respective
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protein sequences (right). Though some inner branchings of the phylogeny are not well sup-
ported, the tree topology clearly shows that the mutation of asparagine to serine at the center
of the active site loop occurred several times independently (red arrow). The four subgroups
(I–IV) identified by the analysis of the multiple sequence alignment using the SPEER server are
indicated on the left-hand side. Furthermore, the remarkable conservation of a tyrosine at the
N-terminus of FicT proteins is clearly apparent (black arrow). The alignment also shows the
distinctiveN-terminal region of a FicT subgroup in Enterobacter (no background coloring)
that does not contain the aforementioned tyrosine.
(TIF)
S4 Fig. Analysis of the genomic context of ficTA loci.The illustration shows the loci encoding
diverse FicTA modules. A small gene (colored in blue) is located directly upstream of the fic
gene (colored in red), corresponding to EcFicA. Note that a ecFicA homolog is encoded
upstream all ecFicT, except in the sequence of Escherichia albertii TW07627 as a result of a sin-
gle point mutation that introduced a stop codon (indicated by a blue star). Furthermore, the
position of ficTA loci between ppiA/B and pabA is conserved for all close enterobacterial homo-
logs of EcFicA (top) while no relevant patterns of synteny can be observed for the other FicTA
loci. Enterobacterial FicT homologs with syntenic loci are displayed above the dotted line.
(TIF)
S5 Fig. Surface representation of FIC domain proteins bound to their respective ligands.
(a) VbhT/VbhAE24G in complex with ATP using the same color code as in Fig 2C with the
active site loop highlighted in yellow (PDB: 3CZB [13]). (b) AnkX in complex with CDP-cho-
line (PBD: 4BET [41]). (c) Apo EcFicTAE28G. Note that the active site pocket is extended on
the side of the base-binding site shown in panel b.
(TIF)
S6 Fig. Comparison of the active site of EcFicT and Fic proteins with various known sub-
strates. The loop corresponding to the Fic signature motif is highlighted in yellow. Residues
involved in diphosphate binding (b-d) or their structural homologs (a) are shown in full. (a)
EcFicTG55R colored in beige with EcFicA colored in blue. (b) VbhT (beige) and VbhAE24G
(pink) in complex with ATP (PDB: 3ZCB [13]). (c) AnkX in complex with CDP-choline (PDB:
4BET [41]). The flap is colored in light blue. (d) Apo Doc/PhD complex (PDB: 3KH2 [46])
with PhD colored in sea green as in S1B Fig.
(TIF)
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